Phyllis R Yale Davita Inc. (DVA) insider trading activity

Phyllis R Yale is Director of DAVITA INC.. Currently has a direct ownership of 12,504 shares of DVA, which is worth approximately $2.13 Million. The most recent transaction as insider was on Dec 02, 2024, when has been sold 3,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 12.5K

20.32% 3M change

14.53% 12M change

Total Value Held $2.13 Million

PHYLLIS R YALE Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2024	SELL Bona fide gift	-	3,500 Reduced 21.87%	12,504 Common Stock
Nov 15 2024	BUY Grant, award, or other acquisition	-	312 Added 1.91%	16,004 Common Stock
Aug 15 2024	BUY Grant, award, or other acquisition	-	333 Added 2.08%	15,692 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	-	363 Added 2.31%	15,359 Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	-	366 Added 2.38%	14,996 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	-	529 Added 3.49%	14,630 Common Stock
Aug 15 2023	BUY Grant, award, or other acquisition	-	475 Added 3.26%	14,101 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	516 Added 3.65%	13,626 Common Stock
May 12 2023	SELL Sale (or disposition) back to the issuer	$474,986 $95.59 p/Share	4,969 Reduced 24.51%	15,306 Common Stock
May 12 2023	SELL Open market or private sale	$209,190 $95.26 p/Share	2,196 Reduced 14.35%	13,110 Common Stock
May 12 2023	BUY Exercise of conversion of derivative security	$474,967 $66.29 p/Share	7,165 Added 26.11%	20,275 Common Stock
Mar 15 2023	BUY Grant, award, or other acquisition	-	658 Added 4.78%	13,110 Common Stock
Nov 15 2022	BUY Grant, award, or other acquisition	-	677 Added 5.16%	12,452 Common Stock
Aug 15 2022	BUY Grant, award, or other acquisition	-	514 Added 4.18%	11,775 Common Stock
May 15 2022	BUY Grant, award, or other acquisition	-	475 Added 4.05%	11,261 Common Stock
Mar 15 2022	BUY Grant, award, or other acquisition	-	429 Added 3.83%	10,786 Common Stock
Nov 15 2021	BUY Grant, award, or other acquisition	-	446 Added 4.13%	10,357 Common Stock
Aug 15 2021	BUY Grant, award, or other acquisition	-	365 Added 3.55%	9,911 Common Stock
Jun 22 2021	SELL Sale (or disposition) back to the issuer	$834,331 $124.36 p/Share	6,709 Reduced 31.49%	14,594 Common Stock
Jun 22 2021	SELL Open market or private sale	$627,618 $124.33 p/Share	5,048 Reduced 34.59%	9,546 Common Stock
Jun 22 2021	BUY Exercise of conversion of derivative security	$850,149 $72.31 p/Share	11,757 Added 38.97%	18,414 Common Stock
May 15 2021	BUY Grant, award, or other acquisition	-	379 Added 3.82%	9,546 Common Stock
Mar 15 2021	BUY Grant, award, or other acquisition	-	436 Added 4.54%	9,167 Common Stock
Nov 15 2020	BUY Grant, award, or other acquisition	-	430 Added 4.69%	8,731 Common Stock

Also insider at

BMY

BRISTOL MYERS SQUIBB CO Healthcare

Director

PRY

Phyllis R Yale

Director

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVA shares.

Notify only if

Value

Insider Trading

Get notified when an Davita Inc. insider buys or sells DVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to DAVITA INC.

Track Activities on DVA

Account